by Hannah Buckelew
The eighth annual NIH Progenitor Cell Translation Consortium (PCTC) 2024 Cardiovascular Bioengineering (CVBE) Symposium was held May 22-25 at Houston Methodist Research Institute in Houston, Texas. The event took place in partnership with The George and Angelina Kostas Research Center for Cardiovascular Nanomedicine Symposium.

On Wednesday, May 22, Jianyi “Jay” Zhang, M.D., Ph.D., FAHA, T. Michael Gillian Goodrich Endowed Chair of Engineering Leadership, Chair, Department of Biomedical Engineering, gave opening remarks. Zhang delivered the talk, titled, “Cells and Cell-Products for Myocardial Repair in Large Animal Models” on Thursday, May 23. He has served on the CVBE Scientific Organizing Committee the past eight years.

Yang Zhou, Ph.D., Assistant Professor, presented the talk, “Epigenetic Determinants of Direct Cardiac Reprogramming” on Friday, May 24.

The goal of the PCTC, a consortium of the National Heart, Lung and Blood Institute (NHLBI), is to translate advances in progenitor cell biology toward application to heart, lung, and blood diseases. The CVBE symposium is a convergence of cardiovascular scientists and engineers, with the participation of top researchers in cardiovascular bioengineering.

View the meeting program here.